These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2652467)

  • 1. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.
    Smith AY; Citterio F; Welsh M; Kerman RH; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1462-4. PubMed ID: 2652467
    [No Abstract]   [Full Text] [Related]  

  • 2. A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients.
    Colvin RB; Preffer FI; Fuller T; Brown M; Ip S; Kung P; Cosimi AB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1863. PubMed ID: 2652605
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-2 receptor positive cell levels in cyclosporin-versus azathioprine-treated renal transplant patients.
    Möhring K; Pomer S; Daniel U; Rambausek M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1469. PubMed ID: 2652470
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble IL-2R assay and spontaneous blastogenesis in the immunological monitoring of kidney transplant patients.
    de Boccardo G; Albano S; Alvarellos T; Massari P; Giraudo C
    Transplant Proc; 1994 Oct; 26(5):2854-6. PubMed ID: 7940899
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology.
    Dittmer R; Harfmann P; Tenschert W; Arndt R; Busch B
    Transplant Proc; 1990 Oct; 22(5):2284-5. PubMed ID: 2219370
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection.
    Cornaby AJ; Simpson MA; Madras PN; Dempsey RA; Clowes GH; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1861-2. PubMed ID: 2652604
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-2 receptor levels in end-stage renal disease and transplant patients.
    Di Stefano R; Carmellini M; Zucchelli G; Clerico A; Masini S; D'Elia F; Fossati N; Ambrogi F; Mosca F
    Transplant Proc; 1990 Aug; 22(4):1863-4. PubMed ID: 2389462
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactivity of peripheral blood lymphocytes to recombinant interleukin-2 in kidney transplant recipients.
    Koda N; Oda T; Yokoyama M; Matsumoto A; Takeuchi M
    Transplant Proc; 1990 Oct; 22(5):2373-5. PubMed ID: 2219405
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring the response to anti-rejection therapy with serum neopterin.
    Smillie AE; Rigby RJ; Petrie JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
    [No Abstract]   [Full Text] [Related]  

  • 10. New markers in serum for lymphocyte activation for predicting allograft rejection. Neopterin and soluble interleukin-2 receptor.
    Carlson IH
    Clin Lab Med; 1992 Mar; 12(1):99-111. PubMed ID: 1563242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection.
    Perkins JD; Nelson DL; Rakela J; Grambsch PM; Krom RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2275-6. PubMed ID: 2540568
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonspecific increase of interleukin-2 receptor serum levels during immune events in heart transplantation.
    De Maria R; Zuccelli GC; Masini S; Caroli A; Brando B; Gronda E; Donato L
    Transplant Proc; 1989 Feb; 21(1 Pt 1):440-1. PubMed ID: 2650169
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of serum interleukin 2 receptor levels in renal allograft recipients.
    Plaza JJ; Blum G; Ortiz A; Hernando L; Feijoo E; Sanz J; Garcia R; Egido J; Ortiz F
    Transplant Proc; 1992 Feb; 24(1):63-4. PubMed ID: 1539346
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression failure: a function of lymphocyte steroid and cyclosporin resistance.
    House AK; Potter JM; Pedersen KE; Kinnear BF; Walker KB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1573-4. PubMed ID: 2652511
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine sediment cytology in the management of renal allograft recipients.
    Madras PN; Simpson MA; Cornaby AJ; Dempsey RA; Clowes GH; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1842-3. PubMed ID: 2652599
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum interleukin 2 activity in renal graft recipients.
    Sunder-Plassmann G; Stockenhuber F; Balcke P
    Transplant Proc; 1988 Jun; 20(3):387-9. PubMed ID: 3289167
    [No Abstract]   [Full Text] [Related]  

  • 18. Soluble CD23 and interleukin-2 receptor levels in renal allograft recipients.
    Beksaç M; Dalva K; Gönenç F; Dalva I; Gariboğlu S; Batur N; Cetin S
    Transplant Proc; 1993 Apr; 25(2):2145-7. PubMed ID: 8470296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cyclosporin A].
    Gabrielli A; Rupoli S
    Recenti Prog Med; 1985 Jun; 76(6):326-31. PubMed ID: 3903888
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of cytologic findings to activation markers in acute liver rejection.
    Lautenschlager I; Höckerstedt K; Häyry P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2290-1. PubMed ID: 2652741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.